Prot# LUN06-116 / H6Q-MC-S034(a): Randomized, Double-Blind, Phase 2 Study of Pemetrexed + Carboplatin + Bevacizumab + Enzastaurin versus Pemetrexed + Carboplatin + Bevacizumab + Placebo in Chemonaive Patients with Stage IIIB or IV Non-Small Cell Lung Canc

Project: Research project

Project Details

Effective start/end date3/6/083/6/11


  • Hoosier Cancer Research Network, Inc. (LUN06-116 / H6Q-MC-S034(a))
  • Eli Lilly and Company (LUN06-116 / H6Q-MC-S034(a))